Full-Time

Real Estate and Construction Attorney

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

Compensation Overview

$188.5k - $234.6k/yr

+ Bonus + Stock-based long-term incentives

Mid, Senior

Thousand Oaks, CA, USA

Category
Legal
Real Estate
Legal & Compliance
Real Estate Development
Real Estate Finance
Requirements
  • J.D. degree or LL.M. degree from an accredited law school
  • Admission to practice law in a U.S. jurisdiction
  • Two (2) years of experience practicing Real Estate and Construction law
Responsibilities
  • Negotiate and draft complex construction contracts and design agreements for large and small projects throughout the United States and internationally.
  • Strong advocate for client’s position in pre-litigation construction disputes, including experience with lien rights, construction defect claims, and enforcement of warranty rights.
  • Negotiate and draft complex purchase and sale agreements and support relevant due diligence activities including familiarity with title insurance policies, surveys, and real estate related environmental matters.
  • Draft and negotiate leases, subleases, and all associated lease documentation.
  • Comfortable advising on complex construction and real estate related issues on projects located throughout the United States and internationally, with the ability to obtain, understand, and communicate to business partners local counsel advice where applicable.
  • Manage outside counsel and outside counsel legal budgets
Desired Qualifications
  • Top tier law firm and/or in-house experience at a multi-national corporation
  • Biotechnology and/or pharmaceutical experience
  • Insurance experience in areas associated with construction and real estate
  • International project experience
  • M&A experience related to real estate assets
  • Familiarity with AIA suite of construction and design agreements
  • Familiarity with lean principles of construction project delivery
  • Subject matter expert in construction and real estate law
  • Ability to work independently, with some supervision, on complex transactions
  • Demonstrated ability to evaluate risk and to exercise sound legal judgment
  • Ability to influence and provide support for other attorneys and paralegals
  • Must be team-oriented and have the ability to work in a fast-paced environment with a solution-oriented approach to legal issues
  • Self-motivated, with outstanding interpersonal skills, and ability to communicate complex concepts and issues effectively with all levels of management
  • Ability to multi-task and work quickly and collaboratively under tight deadlines
  • Highly organized with ability to effectively manage outside counsel

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.